High levels of tumor-infiltrating CD8+ T cells are associated with complete responses to standard chemotherapeutic regimens47, and the presence of CD8+ memory T cells is associated with cancer patients’ survival48,49. The gene discussed is CD8A; the disease is neoplasm.